Navigation Links
Don't Believe What You Hear on Countdown: Keith Olbermann's Factual Errors
Date:2/17/2009

NEW YORK, Feb. 17 /PRNewswire-USNewswire/ -- The following is from Betsy McCaughey, Ph.D., the author of the recent Bloomberg.com article, "Ruin Your Health With the Obama Stimulus Plan."

I am requesting that MSNBC and Keith Olbermann apologize and issue a correction.

Mr. Olbermann charges that I, Betsy McCaughey, Ph.D. was paid, directly or indirectly, by the pharmaceutical industry, the biotech industry, the Hudson Institute, or Cantel Medical Corp. to write my analysis of the stimulus bill or speak about that issue. All these charges are false.

I have shown all these charges to be false in a previous statement except the new charge regarding my board membership at Cantel Medical Corp. I serve on the board of Cantel Medical Corp. as a patient advocate and infection prevention expert. No one at Cantel Medical has ever asked me about the stimulus bill or requested that I address the issue. I have not discussed the issue with anyone in the company. I urge those who are interested to contact Cantel Medical directly (973-890-7220).

I have purchased no stock in Cantel Medical. Like all board members, I am routinely issued options. The options cited by Keith Olbermann were not issued to me in payment for my work on the stimulus bill. They were issued to all Cantel board members at the same time. They are issued routinely and periodically. Unlike the other board members, I have never exercised any options to purchase stock. I do not use those options to make money. The same is true for other boards on which I have served.

Sincerely,

Betsy McCaughey, Ph.D.


'/>"/>
SOURCE Betsy McCaughey
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
2. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
3. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
4. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
5. Affitech Appoints Dr. Keith McCullagh as Chairman
6. Surface Logix Appoints Keith Dionne as President and Chief Executive Officer
7. New Wireless ID Skin Patch Technology Designed to Reduce Medical Errors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):